Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.
IgA nephropathy (IgAN) is a common chronic glomerular disease that, in most patients, slowly progresses to ESRD. The immune and autoimmune responses that characterize IgAN indicate a potential benefit for corticosteroids. The 2012 Kidney Disease Improving Global Outcome (KDIGO) guidelines suggest giving corticosteroids to patients with rather preserved renal function (GFR>50 ml/min per 1.73 m2) and persistent proteinuria >1 g/d, despite 3-6 months of optimized supportive care with renin-angiotensin system blockers. However, the evidence supporting this guideline was considered of low quality. More recent results from large cohort studies and randomized, controlled trials have provided conflicting messages about the benefits of corticosteroid treatment over supportive care alone, mostly involving optimized renin-angiotensin system blockade, which might generate further uncertainty in the therapeutic choice. Overall, these results indicate that corticosteroids are a powerful tool for treating patients with IgAN; however, treatment success is not universal and mostly occurs in patients who are highly proteinuric with early CKD. In patients with advanced CKD, the side effects of corticosteroids increase, and the renal protection decreases. This brief review aimed at integrating the findings of these recently published reports to provide balanced advice for clinicians as well as suggestions for future trials.
Fondazione Ricerca Molinette, Nephrology, Dialysis and Transplantation, Regina Margherita Hospital, Turin, Italy rosanna.coppo@unito.it.
Rosanna
R
Coppo
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D003663:Decision Trees; D005922:Glomerulonephritis, IGA / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System
D000305:Adrenal Cortex Hormones
IgA nephropathy; glomerular disease; immunosuppression; progression of chronic renal failure; risk factors
N Engl J Med. 2016 Mar 10;374(10):991-2
26962738
J Am Soc Nephrol. 2003 Jun;14(6):1578-83
12761258
J Am Soc Nephrol. 2007 Jun;18(6):1880-8
17513327
Nihon Jinzo Gakkai Shi. 1988 Sep;30(9):1135-42
3216556
Kidney Int. 2015 Nov;88(5):974-89
26376134
BMC Nephrol. 2014 Jun 19;15:94
24946688
Kidney Int. 2016 Jan;89(1):167-75
26759049
Am J Kidney Dis. 2006 May;47(5):751-60
16632013
Kidney Int. 2009 Sep;76(5):546-56
19571790
J Am Soc Nephrol. 2008 Jun;19(6):1213-24
18354029
Kidney Int. 2010 Mar;77(5):417-27
20016469
J Am Soc Nephrol. 2007 Dec;18(12):3177-83
17978307
Pediatr Nephrol. 2013 Jan;28(1):71-6
22940909
J Am Soc Nephrol. 2012 Jun;23(6):1108-16
22539830
Clin J Am Soc Nephrol. 2011 Sep;6(9):2175-84
21852672
Am J Kidney Dis. 2013 Nov;62(5):891-9
23820066
Pediatr Nephrol. 2016 Jun 20;:null
27324471
Am J Kidney Dis. 2012 Nov;60(5):812-20
22819700
Am J Kidney Dis. 2001 Oct;38(4):728-35
11576875
Nephrol Dial Transplant. 2015 Mar;30(3):360-6
25387475
N Engl J Med. 2015 Dec 3;373(23):2225-36
26630142
J Am Soc Nephrol. 2002 Jan;13(1):142-8
11752031
Lancet. 1999 Mar 13;353(9156):883-7
10093981
J Am Soc Nephrol. 2004 Jan;15(1):157-63
14694168
Am J Nephrol. 2002 Sep-Dec;22(5-6):480-6
12381947
Nephrol Dial Transplant. 2013 Jul;28(7):1657-62
23539050
Kidney Int. 2009 Sep;76(5):534-45
19571791
Ann Intern Med. 2003 Aug 19;139(4):244-52
12965979
Nat Rev Nephrol. 2010 May;6(5):252-4
20424626
N Engl J Med. 2013 Jun 20;368(25):2402-14
23782179
Expert Opin Med Diagn. 2013 Nov;7(6):615-27
24175678
Antibiot Chemother (1971). 1987;39:41-50
3314686
Nephrol Dial Transplant. 2009 Dec;24(12):3694-701
19628647
J Am Soc Nephrol. 2015 Sep;26(9):2248-58
25677392
J Nephrol. 2005 Sep-Oct;18(5):503-12
16299675
Am J Kidney Dis. 2009 Jan;53(1):26-32
18930568
Nat Rev Nephrol. 2014 Aug;10(8):445-54
24861083
Cochrane Database Syst Rev. 2015 Aug 03;(8):CD003965
26235292
Kidney Int. 2004 Oct;66(4):1403-16
15458433
Kidney Int. 2011 Aug;80(3):310-7
21544062
J Clin Invest. 2009 Jun;119(6):1668-77
19478457
Clin J Am Soc Nephrol. 2011 Oct;6(10):2384-8
21885791
Kidney Int. 2014 Oct;86(4):828-36
24694989
J Am Soc Nephrol. 2010 Oct;21(10):1783-90
20634300
Kidney Int. 2007 Jun;71(11):1148-54
17342176
Br J Clin Pharmacol. 2013 Oct;76(4):516-23
23441592
PLoS One. 2014 Jul 08;9(7):e101935
25003873
J Am Soc Nephrol. 2012 Oct;23(10):1753-60
22956820
Clin J Am Soc Nephrol. 2016 Jun 6;11(6):973-81
27129712
Am J Nephrol. 2011;34(5):435-44
21968096
Kidney Int. 2015 Aug;88(2):276-85
25807036
Results Immunol. 2012 Jan 1;2:166-172
24052934
Am J Kidney Dis. 2016 Sep;68(3):392-401
27032886
Q J Med. 1986 Oct;61(234):935-43
3628707
Nat Genet. 2014 Nov;46(11):1187-96
25305756
J Clin Invest. 2011 Oct;121(10):3991-4002
21881212
Mediators Inflamm. 1996;5(3):191-5
18475715
Nat Rev Immunol. 2012 Dec;12(12):821-32
23103985
Nephrol Dial Transplant. 2009 Jan;24(1):62-72
18685143
Nephrol Dial Transplant. 2008 Jan;23(1):72-81
17898021
Clin J Am Soc Nephrol. 2011 Dec;6(12):2806-13
22157710
J Am Soc Nephrol. 2011 Apr;22(4):752-61
21258035
Singapore Med J. 2001 Aug;42(8):385-9
11764058
Kidney Int. 2004 May;65(5):1544-7
15086888
J Am Soc Nephrol. 2011 Oct;22(10):1795-803
21949093
Annu Rev Pathol. 2013 Jan 24;8:217-40
23092188
Eur J Immunol. 1989 Dec;19(12):2243-9
2606139
Nephrol Dial Transplant. 2003 Jul;18(7):1321-9
12808169
J Nephrol. 2013 Jan-Feb;26(1):86-93
22460183
Nephrol Dial Transplant. 2011 Oct;26(10):3237-42
21378156
Curr Mol Med. 2005 Aug;5(5):475-87
16101476